<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01335243</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2010/21</org_study_id>
    <nct_id>NCT01335243</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow</brief_title>
  <acronym>MatriBone</acronym>
  <official_title>Multicentric, Prospective Study of Efficacy and Safety of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Marrow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biom'Up SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this clinical study is the estimation of the rate of intersomatic
      fusion observed 12 months after lumbar interbody fusion by posterior approach with PEEK
      interbody cage of fusion in PEEK performed with autologous bone of decortication and osseous
      substitute with a biomaterial (MatriBONE associated with the autologous bone marrow),
      associated with a posterolateral bone graft performed with MatriBone waxed with bone marrow.
      Indication is dedicated for patients by painful degenerative osteoarthritis, by narrow lumbar
      canal and\or spondylolisthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical study corresponds to a TLIF surgery using a per-operating artificial substitute
      specific biomaterial: autologous osteoblasts punctured on iliac crest and put on a collagen
      support waxed with tri-calcium phosphate (which is osteoconductive) to perform a
      intervertebral body fusion.

      Biomaterial MATRITM BONE: Device of class III, with marking IT in the indication of
      arthrodesis. It will be administered during the lumbar interbody fusion's procedure.

      The material is a matrix of collagen mineralized containing a homogeneous mixture of collagen
      cleansed of type I+III and an osseous biphasic substitute HA / TCP. The proportion of both
      constituents is 90 % of osseous substitute for 10 % of collagen en masse. The collagen is
      reduced in approximately 1 month and the osseous substitute leads to an osseous reshaping in
      6 - 9 months approximately.

      The follow up will last 12 months with 2 visits (6 and 12 months after surgery), 2 CT scan
      slides before inclusion and at 12 months, classical X-rays before inclusion and at 6 and 12
      months, questionnaires (visual analogic scale for pain, and quality of life with OSWESTRY and
      SF36 scales) before inclusion and at 6 and 12 months, and biological exams (CRP/VS, for
      inflammation) at each visit.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patients' proportion which an intervertebral fusion</measure>
    <time_frame>12 months</time_frame>
    <description>The main assessment criteria of this study are patients' proportion which an intervertebral fusion is documented to CT scanners The intervertebral fusion is documented by the revealing of at least an osseous continuous span of a vertebral level in the other one on one of three CT scan slides centred on the cage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NOTION OF TOLERANCE: Frequency and gravity of unwanted Adverse Events linked to the procedure and\or the use of the biomaterial</measure>
    <time_frame>12 months</time_frame>
    <description>Frequency and gravity of unwanted Adverse Events linked to the procedure and\or the use of the biomaterial:
O Inflammatory or allergic reaction to the tested product (VS and CRP before inclusion).
Non-union turned out and painful
Invalidating lumbar pain
Infection on the operated site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the pain</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluation of the pain with an analogical visual scale (EVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life evaluation</measure>
    <time_frame>12 years</time_frame>
    <description>Quality of life evaluation by means of OSWESTRY and SF-36 scales</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Degenerative Osteoarthritis</condition>
  <condition>Degenerative Lumbar Vertebra</condition>
  <arm_group>
    <arm_group_label>TLIF surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>The Transforaminal Lumbar Interbody Fusion (TLIF) surgery</intervention_name>
    <description>The TLIF surgery use a per-operating artificial substitute specific biomaterial: autologous osteoblasts punctured on iliac crest and put on a collagen support waxed with tri-calcium phosphate (which is osteoconductive) to perform a intervertebral body fusion.</description>
    <arm_group_label>TLIF surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 18 and 65 years old.

          -  Body mass index lower than 35

          -  Degenerative osteoarthritis painful and invalidating degenerative lumbar vertebra for
             at least 6 months and resistance fighter in the conservative treatment

          -  Narrow lumbar canal and\or spondylolisthesis with neurological disorder associated
             with signs of primary instability or induced to neurological liberation

          -  Patient requiring a surgery on a single interbody level.

          -  Given informed consent

          -  Patient with French health system

        Exclusion Criteria:

          -  For women: no efficient contraception (intra uterine device, or contraceptive pill)

          -  Pregnant or feeding women

          -  Surgery zone local infection local

          -  Lumbar interbody fusion of more than two levels

          -  Spondylolisthesis of high rank (stage 3 or 4 of the classification of Meyerding)

          -  Scoliosis lumbar vertebra gives a complex to (Cobb angle&gt; 40°)

          -  All surgical contraindications

          -  Severe hyperparathyroidism: calcium &gt; 2,45 mmol/l and [PTH] ≥ 50pg / ml

          -  Uncontrolled diabetes (untreated or non stabilized by treatment)

          -  Long corticoid treatment (more than 6 months and stopped since less than 3 months)

          -  Current Chemotherapy or during the last three months

          -  Antecedent of regional radiotherapy

          -  All contraindication to MatriTM BONE: osteomyelitis, bone degenerative disease or
             necrosis of surgery site.

          -  Known turned out Osteoporosis untreated (dexa: &gt; 2 DS)

          -  Subject participating in another research including a period of always current
             exclusion in the pre-inclusion

          -  Person placed under protection of justice

          -  Severely altered physical and\or psychological Health, which according to, the
             investigator, can affect to participant's compliance to the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Charles LE HUEC, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoine BENARD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unité d'Orthopédie-Traumatologie rachis II, Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Anand N, Hamilton JF, Perri B, Miraliakbar H, Goldstein T. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome. Spine (Phila Pa 1976). 2006 Sep 15;31(20):E748-53.</citation>
    <PMID>16985443</PMID>
  </reference>
  <reference>
    <citation>Battié MC, Videman T, Levälahti E, Gill K, Kaprio J. Genetic and environmental effects on disc degeneration by phenotype and spinal level: a multivariate twin study. Spine (Phila Pa 1976). 2008 Dec 1;33(25):2801-8. doi: 10.1097/BRS.0b013e31818043b7.</citation>
    <PMID>19050586</PMID>
  </reference>
  <reference>
    <citation>Battié MC, Videman T, Kaprio J, Gibbons LE, Gill K, Manninen H, Saarela J, Peltonen L. The Twin Spine Study: contributions to a changing view of disc degeneration. Spine J. 2009 Jan-Feb;9(1):47-59. doi: 10.1016/j.spinee.2008.11.011.</citation>
    <PMID>19111259</PMID>
  </reference>
  <reference>
    <citation>Carter JD, Swearingen AB, Chaput CD, Rahm MD. Clinical and radiographic assessment of transforaminal lumbar interbody fusion using HEALOS collagen-hydroxyapatite sponge with autologous bone marrow aspirate. Spine J. 2009 Jun;9(6):434-8. doi: 10.1016/j.spinee.2008.11.004. Epub 2008 Dec 25.</citation>
    <PMID>19111510</PMID>
  </reference>
  <reference>
    <citation>Chen Z, Zhao J, Liu A, Yuan J, Li Z. Surgical treatment of recurrent lumbar disc herniation by transforaminal lumbar interbody fusion. Int Orthop. 2009 Feb;33(1):197-201. doi: 10.1007/s00264-008-0531-1. Epub 2008 Mar 21.</citation>
    <PMID>18357449</PMID>
  </reference>
  <reference>
    <citation>el-Masry MA, Khayal H, Salah H. Unilateral transforaminal lumbar interbody fusion (TLIF) using a single cage for treatment of low grade lytic spondylolisthesis. Acta Orthop Belg. 2008 Oct;74(5):667-71.</citation>
    <PMID>19058702</PMID>
  </reference>
  <reference>
    <citation>Goyal N, Wimberley DW, Hyatt A, Zeiller S, Vaccaro AR, Hilibrand AS, Albert TJ. Radiographic and clinical outcomes after instrumented reduction and transforaminal lumbar interbody fusion of mid and high-grade isthmic spondylolisthesis. J Spinal Disord Tech. 2009 Jul;22(5):321-7. doi: 10.1097/BSD.0b013e318182cdab.</citation>
    <PMID>19525786</PMID>
  </reference>
  <reference>
    <citation>Houten JK, Post NH, Dryer JW, Errico TJ. Clinical and radiographically/neuroimaging documented outcome in transforaminal lumbar interbody fusion. Neurosurg Focus. 2006 Mar 15;20(3):E8.</citation>
    <PMID>16599424</PMID>
  </reference>
  <reference>
    <citation>Jagannathan J, Sansur CA, Oskouian RJ Jr, Fu KM, Shaffrey CI. Radiographic restoration of lumbar alignment after transforaminal lumbar interbody fusion. Neurosurgery. 2009 May;64(5):955-63; discussion 963-4. doi: 10.1227/01.NEU.0000343544.77456.46.</citation>
    <PMID>19404155</PMID>
  </reference>
  <reference>
    <citation>Lauber S, Schulte TL, Liljenqvist U, Halm H, Hackenberg L. Clinical and radiologic 2-4-year results of transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Spine (Phila Pa 1976). 2006 Jul 1;31(15):1693-8.</citation>
    <PMID>16816765</PMID>
  </reference>
  <reference>
    <citation>Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, Hilibrand AS, Albert TJ. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 2009 Aug;9(8):623-9. doi: 10.1016/j.spinee.2009.04.004. Epub 2009 May 30.</citation>
    <PMID>19482519</PMID>
  </reference>
  <reference>
    <citation>Rihn JA, Makda J, Hong J, Patel R, Hilibrand AS, Anderson DG, Vaccaro AR, Albert TJ. The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis. Eur Spine J. 2009 Nov;18(11):1629-36. doi: 10.1007/s00586-009-1046-1. Epub 2009 May 28.</citation>
    <PMID>19475434</PMID>
  </reference>
  <reference>
    <citation>Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech. 2005 Feb;18 Suppl:S77-81.</citation>
    <PMID>15699810</PMID>
  </reference>
  <reference>
    <citation>Schleicher P, Beth P, Ottenbacher A, Pflugmacher R, Scholz M, Schnake KJ, Haas NP, Kandziora F. Biomechanical evaluation of different asymmetrical posterior stabilization methods for minimally invasive transforaminal lumbar interbody fusion. J Neurosurg Spine. 2008 Oct;9(4):363-71. doi: 10.3171/SPI.2008.9.10.363.</citation>
    <PMID>18939923</PMID>
  </reference>
  <reference>
    <citation>Xiao Y, Li F, Chen Q. Transforaminal lumbar interbody fusion with one cage and excised local bone. Arch Orthop Trauma Surg. 2010 May;130(5):591-7. doi: 10.1007/s00402-009-0917-6. Epub 2009 Jun 30.</citation>
    <PMID>19565252</PMID>
  </reference>
  <reference>
    <citation>Xiao YX, Chen QX, Li FC. Unilateral transforaminal lumbar interbody fusion: a review of the technique, indications and graft materials. J Int Med Res. 2009 May-Jun;37(3):908-17. Review.</citation>
    <PMID>19589277</PMID>
  </reference>
  <reference>
    <citation>Yan DL, Pei FX, Li J, Soo CL. Comparative study of PILF and TLIF treatment in adult degenerative spondylolisthesis. Eur Spine J. 2008 Oct;17(10):1311-6. doi: 10.1007/s00586-008-0739-1. Epub 2008 Aug 7.</citation>
    <PMID>18685873</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2011</study_first_submitted>
  <study_first_submitted_qc>April 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2011</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Orthopedic Procedures</keyword>
  <keyword>Spine</keyword>
  <keyword>Interbody fusion</keyword>
  <keyword>Arthrodesis</keyword>
  <keyword>Lumbar Vertebrae</keyword>
  <keyword>CT Scan</keyword>
  <keyword>Spine balance</keyword>
  <keyword>Instrumented fusion</keyword>
  <keyword>Posterior fusion</keyword>
  <keyword>Degenerative spine</keyword>
  <keyword>painful</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

